HB 153 KY
AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Sponsors (12)
- L. Willner Democratic · primary
- C. Aull Democratic · primary
- S. Bratcher Republican · primary
- B. Chester-Burton Democratic · primary
- K. Fleming Republican · primary
- D. Grossberg Democratic · primary
- V. Grossl Republican · primary
- C. Lewis Republican · primary
- K. Moser Republican · primary
- J. Nemes Republican · primary
- R. Roarx Democratic · primary
- S. Stalker Democratic · primary
Action history (3)
- Jan 7, 2026 introduced in House · lower
- Jan 7, 2026 to Committee on Committees (H) · lower
- Jan 14, 2026 to Health Services (H) · lower
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments